Tema Oncology ETF (CANC US) stock market data APIs
35.1846
0.65(1.8%)
as of December 26, 2025
Try our APIs with
free plan!
Tema Oncology ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
35.1846
Open
35.8377
High
35.9807
Low
35.1778
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Tema Oncology ETF data using free add-ons & libraries
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Tema Oncology ETF News
New
Healthcare stocks are red-hot. Here are 3 picks from a fund manager up 41% this year.
Healthcare stocks have outperformed the technology sector since September. The Tema Oncology ETF is one fund that has had enjoyed a big rally, up 41% this year. David Song, the fund's manager, highlig...
Be Thankful to These ETFs This Year
As Americans prepare for Thanksgiving, investors have their own reasons to be grateful this year – despite a year marked by dramatic twists in geopolitical scenario, technological sphere and Fed pol...
Inside the Recent Strength in Biotech ETFs
Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB has rallied about 35% over the past six months (as of Nov. 20, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 12%). Year to...
SA Asks: Which oncology companies are attractive M&A targets?
[word m and a made with wood building blocks, stock image] Maksim Labkouski Which cancer drug developers are attractive takeover targets? We asked Seeking Alpha analysts BioCGT Investor [https://see...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
